Albumin-binding capacity (ABiC) is reduced in patients with chronic kidney disease along with an accumulation of protein-bound uraemic toxins
- 15 November 2011
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (6), 2377-2383
- https://doi.org/10.1093/ndt/gfr616
Abstract
Albumin is an important transport protein for non-water-soluble protein-bound drugs and uraemic toxins. Its transport capacity is reduced in patients with advanced chronic kidney disease (CKD) and unbound fractions of uraemic toxins are related to complications of CKD. We investigated whether this reduction could be quantified and how it correlated with the stages of CKD. Albumin-binding capacity (ABiC) is a dye-based method that quantifies the remaining binding capacity of one major binding site (site II) of the albumin molecule. Blood samples from 104 CKD patients were incubated with a binding site-specific fluorescent marker and the amount of unbound marker was determined by means of fluorescence detection after filtration. Measurements in a pooled human plasma were used for reference. Glomerular filtration rate and serum indoxyl sulphate (IS) levels were also determined. Impairment of renal function was associated with a reduction in ABiC (mean ± SD: 118 ± 12; 111 ± 11; 99 ± 8 and 79 ± 9% for Stages 1/2, 3, 4 and 5, respectively; P < 0.001) and an increase in IS (3.9 ± 1.1; 6.2 ± 3.2; 16.3 ± 14.9 and 56.1 ± 28.6 μmol/L for Stages 1/2, 3, 4 and 5, respectively; P < 0.001). In dialysis patients, ABiC was lower in those with urine outputs <500 mL/day than in those with preserved urine output (73.7 ± 6.0 versus 83.8 ± 8.5%; P < 0.001). Impaired albumin function in CKD patients can be quantified, is related to severity of kidney disease and is associated with an accumulation of uraemic albumin-bound retention solutes.Keywords
This publication has 48 references indexed in Scilit:
- p-Cresyl Sulfate and Indoxyl Sulfate in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease PatientsClinical Journal of the American Society of Nephrology, 2009
- Albumin thiol oxidation and serum protein carbonyl formation are progressively enhanced with advancing stages of chronic kidney diseaseClinical and Experimental Nephrology, 2009
- Effect of Membrane Permeability on Survival of Hemodialysis PatientsJournal of the American Society of Nephrology, 2009
- Impaired Tubular Uptake Explains Albuminuria in Early Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Uremic Toxins: What Are They? An Integrated Overview of Pathobiology and ClassificationJournal of Renal Nutrition, 2008
- Physiological and pathological changes in the redox state of human serum albumin critically influence its binding propertiesBritish Journal of Pharmacology, 2007
- Impairments of the biological properties of serum albumin in patients on haemodialysisNephrology, 2007
- The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burstBiochemical and Biophysical Research Communications, 2005
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003